Session 10: Emerging strategies in neoadjuvant treatment of patients with HER2 positive early br...

Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast CancerПодробнее

HER2+ Early-Stage Breast Cancer: Neoadjuvant StrategiesПодробнее

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott ChristensenПодробнее

Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее

Emerging strategies to overcome resistance to HER2 ADCs in breast cancerПодробнее

Treatment de-escalation and escalation strategies in HER2-positive breast cancerПодробнее

Overview of Neoadjuvant Therapy in HER2+ Breast CancerПодробнее

Neoadjuvant Treatment Strategies for HER2-Positive Breast CancerПодробнее

Session 10: Neoadjuvant and adjuvant treatment of patients with TNBC (Javier Cortes, Spain)Подробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. SolimanПодробнее

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancerПодробнее

Case 1: Clinical Trials in Early-Stage HER2+ Breast CancerПодробнее

SABCS Snippets: SHR-A1811 in the Neoadjuvant Treatment of HER2-positive Early Breast CancerПодробнее

Refining Neoadjuvant Chemotherapy for HER2+ Breast CancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. GradisharПодробнее

St. Gallen Consensus 2021: neoadjuvant and adjuvant therapy for HER2+ breast cancerПодробнее

Strategies for Improving Neoadjuvant Therapy Decision-making for HER2+ Breast CancerПодробнее

Neo-PATH: TAHP for patients with HER2-positive breast cancerПодробнее

Analyzing Predictors of Response to Neoadjuvant Chemotherapy in Breast CancerПодробнее